Categories |
|
Latest Reports |
|
Biotechnology
Cancer
Consumer
Customer Relationship Management
Drug Delivery
eHealthcare Pharma
Generics
Healthcare
Medical Devices
OTC Pharmaceuticals
Pharmaceuticals
Pharmacoeconomics
Therapeutic Areas:
- Cardiovascular
- Central Nervous System
- Immune Disorders and Inflammation
- Infectious Diseases
- Oncology
- Women'sHealth
|
|
|
- Pipeline Insight: HIV - Enter the New Generation Inhibitors 26-April-2004
In-depth appraisal of HIV antiretroviral pipeline covering Phase I to Phase III candidates in NRTI, NNRTI, PI and EI classes, including critical appraisal of product profile, clinical trial design and global forecasts to 2012.
------------------------------------------------------------------------------------------------------------------------- |
- Biogenerics: Drivers and Resistors of Market Development 26-April-2004
With several blockbuster biological products approaching patent expiry, the biogenerics segment represents an attractive opportunity for companies looking to escape intensifying competition in the commodity generics sector.
------------------------------------------------------------------------------------------------------------------------- |
- Permission Based Marketing: Providing Consumers Personalized Online Marketing 23-April-2004
Overview of permission based marketing and the opportunities offered by this type of marketing. The report examines the principal methods of gaining permission from consumers, what information to provide and what channels to use.
-------------------------------------------------------------------------------------------------------------------------
|
- Addressing Pharma’s R&D Productivity Crisis: Technological and Strategic Initiatives to Improve Core Drug Discovery Capabilities 20-April-2004
Analysis of the R&D crisis facing the pharmaceutical industry, examining the factors underlying poor productivity, including the technological and strategic opportunities available for strengthening core drug discovery expertise and productivity.
------------------------------------------------------------------------------------------------------------------------- |
- Innovative Agents in Lung and Colorectal Cancer - Another Step Nearer the Revolution? 20-April 2004
The role of EGFR inhibitors and the future trends for use of innovative agents in the non-small cell lung and colorectal cancer market.
-------------------------------------------------------------------------------------------------------------------------
|
- eHealth Regulations in Europe: Understanding the Changing European Legislative Landscape 20-April-2004
Analysis of the changing eHealth regulatory environment in Europe, including discussion of trends and general strategies for regulatory compliance.
------------------------------------------------------------------------------------------------------------------------- |
- Stakeholder Opinions: Malignant Melanoma - High Hurdles, High Rewards, Are Vaccines Only Skin Deep? 16-April-2004
Key issues in the malignant melanoma market, including current diagnosis and treatment patterns, insight into pipeline drugs, and stakeholder opinions.
------------------------------------------------------------------------------------------------------------------------- |
| |
| |
